Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
3
×
deals
life sciences
national blog main
national top stories
boston
fda
new york blog main
roche
alirocumab
alnylam pharmaceuticals
amgen
biopharma
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
daniel o'day
duchenne
europe blog main
europe top stories
evolocumab
foundation medicine
foundationone cdx
foundationone heme
genentech
inclisiran
licensing
m&a
muscular dystrophy
new york
new york top stories
novartis
osimertinib
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
What
billion
3
×
acquire
agreed
deal
fda
medicine
recently
roche
approval
betting
big
biopharma
brings
broad
cash
cholesterol
company
compound
confidence
didn’t
drug
duchenne
foundation
gain
gene
genentech
historic
medco
medicines
momentum
morning
new
novartis
panels
pay
pays
picked
poised
profiling
puts
Language
unset
Current search:
billion
×
biotech
×
" boston top stories "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine